Peakdale Molecular - News

PEAKDALE MOLECULAR STRENGTHENS MANAGEMENT TEAM

Chapel-en-le-Frith, UK, 5th March 2008

Peakdale Molecular, the chemistry development and medicinal chemistry company announces it has appointed Dr. Paul Doyle as its Director of Technology.

Paul brings more than 25 years knowledge of drug discovery and technology to Peakdale Molecular, with experience across most therapeutic areas.

Paul was most recently Technical Director at BioFocus (now BioFocus DPI, a Galapagos company) where between 1997 and 2003, he was a founding scientist and Director of Chemistry.

From 1981 to 1996, he held a variety of senior positions in research for the Wellcome Foundation at Beckenham in Kent, culminating in Senior Research Scientist for the Drug Discovery Unit.

Paul holds a degree in chemistry from New College, Oxford and achieved his D.Phil. at the University of Sussex in 1981. He has previously been Secretary to the UK Peptide and Protein Group and was one of the instigators of the BioMolecular Structure Unit at the University of Sussex.

Dr. Ray Fisher, CEO of Peakdale commented: "Paul's experience and proven track record in providing Modern Medicinal Chemical solutions to the drug discovery and development programs of emerging BioPharma make him a strategic recruitment and reinforces Peakdale's ambitions in this arena."

FOR MORE INFORMATION REGARDING THIS NEWS
ARTICLE PLEASE CONTACT

Sarah Barratt
Marketing Executive
Peakdale Molecular Ltd
01298 816 700
sarah.barratt@peakdale.co.uk